Wanbangde Pharmaceutical Holding Group Co., Ltd. (002082.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap8.65B
Enterprise Value8.92B
P/E Ratio-478.6
PEG Ratio0.86
Price/Sales Ratio6.59
Price/Book Ratio3.01
Enterprise/Revenue6.79
Enterprise/EBITDA-552.92

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.09
Operating Margin-0.06
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.04

Income Statement

Revenue1.12B
Revenue/Share1.99
Gross Profit1.14B
EBITDA-23.08M
Net Income-167.24M
Diluted EPS-0.32

Balance Sheet

Total Cash575.01M
Total Cash/Share0.95
Total Debt816.78M
Total Debt/Equity0.31
Current Ratio1.23
Book Value Per Share4.45

Price History

52-Week Change93.87
52-Week High36.24
52-Week Low6.47
Moving Average 50 Days20.91
Moving Average 200 Days17.19

Statistics

Average Volume29.27M
Shares Outstanding611.69M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.35
Last Split Factor8:5
Last Split DateJune 10, 2008
AD